| |
| |
|
| Insider
Information: |
Macdougall Ann L. |
| Relationship: |
Director |
| City: |
Santa Monica |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
0 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
0 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
3
|
|
Stock
price went up :
|
1
|
3
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
1.0
|
3.0
|
| Percentage
Gain/Loss : |
 66.8%
|
444.8%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Opiant Pharmaceuticals Inc |
OPNT |
Director |
2023-03-02 |
0 |
2018-06-04 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
13 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| OPNT |
Opiant Pharmaceuticals In... |
Director |
– • – |
2023-03-02 |
4 |
D |
$20.00 |
$563,580 |
D/D |
(28,179) |
0 |
0 |
- |
|
| OPNT |
Opiant Pharmaceuticals In... |
Director |
– • – |
2022-05-13 |
4 |
B |
$10.93 |
$32,778 |
D/D |
3,000 |
26,179 |
2.39 |
% |
|
| OPNT |
Opiant Pharmaceuticals In... |
Director |
– • – |
2021-05-13 |
4 |
OE |
$10.00 |
$3,410 |
D/D |
341 |
21,179 |
0 |
- |
|
| OPNT |
Opiant Pharmaceuticals In... |
Director |
– • – |
2021-03-17 |
4 |
S |
$11.07 |
$73,128 |
D/D |
(6,606) |
20,838 |
0 |
% |
|
| OPNT |
Opiant Pharmaceuticals In... |
Director |
– • – |
2021-03-17 |
4 |
OE |
$10.00 |
$72,790 |
D/D |
7,279 |
27,444 |
0 |
- |
|
| OPNT |
Opiant Pharmaceuticals In... |
Director |
– • – |
2021-03-16 |
4 |
S |
$11.50 |
$22,414 |
D/D |
(1,949) |
20,165 |
0 |
% |
|
| OPNT |
Opiant Pharmaceuticals In... |
Director |
– • – |
2021-03-16 |
4 |
OE |
$10.00 |
$22,310 |
D/D |
2,231 |
22,114 |
0 |
- |
|
| OPNT |
Opiant Pharmaceuticals In... |
Director |
– • – |
2021-03-15 |
4 |
S |
$11.63 |
$65,128 |
D/D |
(5,600) |
19,883 |
0 |
% |
|
| OPNT |
Opiant Pharmaceuticals In... |
Director |
– • – |
2021-03-15 |
4 |
OE |
$10.00 |
$64,830 |
D/D |
6,483 |
25,483 |
0 |
- |
|
| OPNT |
Opiant Pharmaceuticals In... |
Director |
– • – |
2021-02-11 |
4 |
OE |
$10.00 |
$70,000 |
D/D |
7,000 |
19,000 |
0 |
- |
|
| OPNT |
Opiant Pharmaceuticals In... |
Director |
– • – |
2020-06-15 |
4 |
A |
$0.00 |
$0 |
D/D |
2,000 |
12,000 |
0 |
- |
|
| OPNT |
Opiant Pharmaceuticals In... |
Director |
– • – |
2019-12-12 |
4 |
B |
$14.54 |
$72,700 |
D/D |
5,000 |
10,000 |
2.39 |
- |
|
| OPNT |
Opiant Pharmaceuticals In... |
Director |
– • – |
2018-06-04 |
4 |
B |
$15.70 |
$82,567 |
D/D |
5,000 |
5,000 |
2.39 |
- |
|
13 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
